Top Chicago, IL Big Data Companies With Best Stability & Growth (210)

Strong Revenue Growth: Clearing fee revenue and net income increased sharply in 2025 alongside record contract volumes, and 2026 monthly updates indicate continued double‑digit year‑over‑year activity. These trends point to rising financial throughput consistent with accelerated operating scale.

Market Expansion: The organization began clearing for MIAX Futures in May 2026, extending coverage to 21 exchanges and trading platforms. This broader network signals a widening footprint across venues and products.

Strong Market Position & Advantage: As the sole central counterparty for U.S. listed options and a designated SIFMU, it operates from an entrenched position with unmatched scale. Record multi‑year volumes and substantial risk resources reinforce that advantage.

Strong Market Position & Advantage: Leadership positions across biscuits (#1) and chocolate (#2), anchored by iconic brands and a presence in 150+ countries, support pricing power and distribution reach. Category and geographic breadth are cited as underpinning mid‑term growth capacity.

Resilient & Sustainable Growth: Net revenues and organic net revenue increased in 2025 and remained positive into 2026 despite a tougher cost environment and moderating pace. Management signals potential to reaccelerate profitable growth as cocoa costs stabilize and productivity programs take hold.

Healthy Cash Flow: Guidance for 2026 targets approximately $3 billion in free cash flow, alongside maintained capital returns such as a dividend increase. This cash generation supports continued reinvestment behind brands and execution.

Strong Revenue Growth: Revenue expanded rapidly, with FY2025 up 83% to about $1.27B and Q1/Q2 2026 up 36% and 22% year over year, respectively. Management also raised 2026 revenue guidance to approximately $1.595–$1.605B.

Diversified Revenue Streams: Both Diagnostics and Data & Applications are expanding, with Diagnostics up 34.7% in Q1 and 20% in Q2 2026 and Insights/data licensing up 36% in Q2 alongside about $200M in new licenses. Rising oncology test volumes (28–31% YoY) and accelerating MRD tests (~4,700 in Q4 2025 to ~9,000 in Q2 2026) reinforce multiple growth engines.

Profitability: The company achieved its first GAAP-profitable quarter in Q2 2026 (net income about $5.6M; Adjusted EBITDA ~$8.0M). Guidance points to further improvement in 2026, indicating progress toward sustained profitability.

Strong Revenue Growth: Recent results show revenue up 9.6% year over year in Q2 2026 (6.8% organic; 8.2% excluding product sunsets), with 2025 up 7.5% and year‑to‑date 2026 up 10.2% on a reported basis. Growth is led by Morningstar Credit and core data/software platforms such as Morningstar Direct and PitchBook.

Profitability: Operating and adjusted operating margins expanded in Q2 2026 alongside a 29% rise in adjusted diluted EPS to $3.10, and 2025 saw increases in operating income and adjusted operating income. These gains were supported by stronger contribution from Credit and the accretive effect of the CRSP acquisition.

Healthy Cash Flow: Free cash flow and operating cash flow increased sharply in Q2 2026, with free cash flow nearly doubling year over year. This improved cash generation coincided with active buybacks and dividends.

Strong Revenue Growth: Company communications describe ARR more than tripling in 2025, marking its strongest year to date. These disclosures point to clear top‑line momentum into 2026.

Product Line Growth: Announcements highlight expanded AI functionality for healthcare in June 2026 alongside ongoing platform updates. This indicates continued investment in new capabilities and vertical depth.

Strong Hiring & Retention: Multiple senior appointments in mid‑2026, including an EVP of Technology & Operations and additional leadership roles, suggest active scaling of the executive and technical bench. References to broader team expansion reinforce organizational build‑out.

Investor Backing & Capital Strength: Recent growth-capital rounds (a $4.5M non-dilutive facility in 2021 and an RF Investment Partners investment in 2023) are positioned to accelerate expansion, operations, and product development. These moves align with multi‑year scaling plans and potential M&A.

Market Expansion: Geographic growth is evident with a new Bangalore office (2023) and a move into larger Chicago office space, alongside continued hiring signals and public language of fast growth. These steps point to expanding capacity and footprint across locations.

Strong Hiring & Retention: The addition of a VP of Product in January 2026 and active recruiting for roles like Demand Generation Manager indicate scaling teams and roadmap ambition. Consecutive Built In “Best Places to Work” badges through 2026 support employer attractiveness.

Diversified Customer Base: Customer count expanded from more than 1,200 brands in 2023 to 1,600+ by 2026, indicating broader adoption across regions and modes.

Innovation-Driven Growth: Multiple 2026 launches—Loft AI, Inventory Twin enhancements, and an agentic ocean booking platform—signal an active roadmap and continued go‑to‑market motion.

Strong Market Position & Advantage: Being named a Leader in Gartner’s 2024 Magic Quadrant for RTTVPs reflects established competitive standing heading into 2025.

Strong Revenue Growth: Revenue is advancing at a double‑digit pace in early 2026, with successive quarters outperforming internal targets and full‑year guidance raised. Momentum is driven by U.S. Financial Services and improving International trends.

Profitability: Earnings are expanding, with adjusted EBITDA and adjusted EPS up year over year and full‑year guidance implying further gains. Absolute EBITDA improved even as the company invested and integrated recent acquisitions.

Market Expansion: Reach is widening through improved performance in Canada, the U.K., and India, alongside completed acquisitions in Mexico and a mobile division that extend capabilities. These moves contributed to stronger reported results and a higher outlook.

Strategic Partnerships: The acquisition by Model N positions Kalderos’s 340B and gross-to-net capabilities inside a larger life-sciences revenue platform, implying broader distribution and customer access. Integration of the Truzo claims-level visibility into Model N’s suite signals strategic value and scale-up potential.

Strong Revenue Growth: Company materials state revenue more than doubled two years in a row leading into 2023, alongside expanding customers and team. These signals point to strong pre-acquisition traction that can be leveraged under Model N.

Market Expansion: 340B drug purchases reached roughly $66.3B in 2023, indicating a large and expanding market the combined offering serves. This category tailwind supports ongoing demand for discount-management and gross-to-net solutions.

Strong Revenue Growth: Recent quarters show sharp year-over-year increases in net revenue, surpassing the billion‑dollar mark per quarter as GMV and transaction volume expand. Feedback suggests this momentum is broad‑based across multiple operating metrics rather than isolated to a single line item.

Profitability: GAAP operating income and net income turned positive in fiscal 2026 quarters, signaling improved operating leverage and margins. Company filings indicate this profitability coincides with higher volumes rather than coming solely from cost actions.

Market Expansion: Active consumers and merchants increased meaningfully, with transactions per active consumer also rising. Direct‑to‑consumer offerings—especially the Affirm Card—scaled rapidly and diversified activity beyond the largest partners.

Innovation-Driven Growth: Regulatory momentum is evident with FDA 510(k) clearance for the eVO2peak Module and references to multiple FDA-cleared algorithms, alongside ISO 13485 and MDSAP certifications. Ongoing clinical activity and datasets (e.g., OCORO Heart Study, multi‑million hours of heart data) point to a steadily expanding product and evidence base.

Strategic Partnerships: The March 27, 2025 acquisition by Kardigan integrates Prolaio’s FDA‑cleared software, curated CV datasets, and analytics into a larger R&D platform, signaling added resources and scope. Materials indicate Prolaio continues operating independently while benefiting from Kardigan’s broader heart‑health strategy.

Strong Hiring & Retention: Hiring signals are visible through an active careers page, a stated 32 new hires in 2025, and multiple current openings across functions. Employer recognition such as “Best Places to Work 2026” and ongoing recruiting activity suggest team expansion and brand momentum.

Profitability: Adjusted EBITDA and ex‑TAC gross profit are rising at double‑digit rates, with Q2 margins expanding and management raising full‑year profitability guidance. This points to increasing operating leverage even as mix shifts favor higher‑margin revenue.

Strategic Partnerships: A 30‑year exclusive native‑ads agreement with Yahoo is live globally and framed as a multi‑year growth driver with sizable revenue potential. Recent publisher wins such as Fox News further extend distribution that supports current results and the outlook.

Innovation-Driven Growth: Momentum in the Realize performance offering and AI initiatives like DeeperDive are cited as contributors to improved results and raised guidance. These offerings indicate continued product evolution beyond classic native formats.

Strong Revenue Growth: Revenue scale is signaled by surpassing $500M in annual recurring revenue in July 2023, creating a high base for subsequent expansion. Company communications frame later moves as building on this milestone.

Market Expansion: Recent acquisitions—Spatial Business Systems, PDS Energy’s exchange platforms, and TGS’s A2D well log library—extend reach into utilities engineering, operational exchanges, and subsurface data. Solutions marketed across upstream, midstream, power and renewables point to a broadening footprint.

Investor Backing & Capital Strength: Blackstone agreed in August 2025 to acquire Enverus in a deal reported at $6.5B+ and later referenced deploying capital into the company in 1Q26. This indicates substantial resources and conviction to support further scaling.

Strong Revenue Growth: Consecutive Inc. 5000 placements in 2023 and 2024 and the company’s statement that it doubled revenue between 2019 and 2022 point to sustained top-line momentum over recent multi-year periods.

Investor Backing & Capital Strength: A February 27, 2025 growth‑equity investment from Boathouse Capital is explicitly earmarked to scale hiring, expand services and enter new markets, and potentially support M&A.

Market Expansion: Expansion moves such as acquiring Mashey, establishing an international team in Bulgaria, and enlarging its Chicago headquarters indicate a deliberate scale‑up of footprint and delivery capacity.

Market Expansion: Multi‑year acquisitions—Snow Software (2024), NetApp’s Spot FinOps portfolio (2025), and ProsperOps plus Chaos Genius (2026)—broaden coverage across ITAM, SaaS, FinOps, and AI/data‑cloud cost optimization. Ongoing 2026 Flexera One releases, including a ProsperOps+ FinOps suite, reinforce expansion into Kubernetes/container and AI cost domains.

Strong Market Position & Advantage: Leader placements in Gartner’s 2025–2026 SaaS Management Platforms MQ and 2024–2025 Cloud Financial Management Tools MQ indicate competitive strength across core segments. Company materials and State of the Cloud/ITAM reports further underscore presence with large enterprises.

Innovation-Driven Growth: Continuous 2026 feature updates to Flexera One and the launch of AI Cost Management signal active product investment. Agentic/AI capabilities added via ProsperOps and Chaos Genius enhance automation in cloud and data‑cloud optimization.